<DOC>
	<DOCNO>NCT00553917</DOCNO>
	<brief_summary>The purpose study evaluate pregnancy , common group antidepressant medication ( SSRI 's ) adequately treat symptom depression evaluate effect medication newborn infant .</brief_summary>
	<brief_title>Study Evaluate Effectiveness Certain Selective Serotonin Reuptake Inhibitor ( SSRI ) Antidepressants During Pregnancy Evaluate Newborn Outcomes</brief_title>
	<detailed_description>The amount level antidepressant medication blood ( e.g . selective serotonin reuptake inhibitor SSRIs ) seem decreased pregnancy . If level SSRIs blood low , medication may adequately treat depression . The objective study evaluate whether pregnant woman decrease level SSRIs resultant decrease improvement depression SSRIs . We also want evaluate whether variation gene relate body eliminate SSRIs SSRIs work influence improvement depression pregnant woman experience drug . We conduct study 100 pregnant woman receive fluoxetine ( n = 25 ) sertraline ( n = 25 ) treatment depression , receive medication depression ( n = 25 ) , pregnant history treatment depression ( n= 25 ) . Participants enrol time 26 week pregnancy . Blood sample collect genetic analysis subject , drug level measurement pregnancy , delivery , post partum subject take antidepressant medication . We also monitor monthly platelet serotonin level group . In addition , score rating scale measure severity depression two rating scale measure undesirable effect treatment obtain enrollment monthly 12 week delivery . Maternal umbilical cord blood sample obtain delivery determination SSRI level , platelet serotonin level ( marker SSRIs work ) , collection neonatal DNA . After delivery mother complete survey feeling baby , baby 's behavior observe 1 hour time interval . Babies mother take medication blood sample drawn 2-3 month birth measure drug level compare cord blood sample delivery . We plan collect breastmilk sample mother medicate arm choose breastfeed . Clinical data related pregnancy neonatal health obtain prenatal neonatal chart .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Pregnant woman 18 40 year age Have depression mental health disorder Have receive fluoxetine citalopram treatment depression least one month day study entry patient fluoxetine citalopram arm , pharmacological treatment patient control arm â‰¤ 26 week pregnant estimate date confinement Ability give inform consent Singleton pregnancy Pregnant woman history depression Having comorbid mental disorder generalize anxiety disorder secondary disorder History current epilepsy , endocrine , cardiac , pulmonary , renal hepatic dysfunction could negatively influence pregnancy and/or neonatal outcome Abusing alcohol drug Use self prescribe herbal treatment depression</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Depression</keyword>
	<keyword>Antidepressants</keyword>
</DOC>